Livongo health, inc. (LVGO)
Income statement / Yearly
Dec'19Dec'18Dec'17
Revenue

170,198

68,431

30,850

Cost of revenue

46,158

20,269

8,312

Gross profit

124,040

48,162

22,538

Operating expenses:
Research and development

49,842

24,861

12,028

Sales and marketing

78,060

36,433

16,502

General and administrative

55,676

23,063

11,050

Change in fair value of contingent consideration

843

-1,200

0

Total operating expenses

184,421

83,157

39,580

Loss from operations

-60,381

-34,995

-17,042

Other income, net

3,742

1,641

123

Loss before provision for income taxes

-56,639

-33,354

-16,919

Income Tax Expense (Benefit)

-1,369

28

-61

Net Income (Loss) Attributable to Parent

-55,270

-33,382

-16,858

Temporary Equity, Accretion to Redemption Value, Adjustment

96

162

143

Net loss attributable to common stockholders

-55,366

-33,544

-17,001

Net loss per share attributable to common stockholders, basic and diluted (in dollars per share)

-1.09

-2.02

-1.18

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted (in shares)

50,930

16,573

14,442